Jpmorgan Chase & CO Kodiak Sciences Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 44,648 shares of KOD stock, worth $276,371. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,648
Previous 13,913
220.91%
Holding current value
$276,371
Previous $32,000
262.5%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding KOD
# of Institutions
97Shares Held
39MCall Options Held
6.5KPut Options Held
5.8K-
Baker Bros. Advisors LP New York, NY17.3MShares$107 Million0.48% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$23.8 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$12.1 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$10.4 Million0.0% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.02MShares$6.29 Million0.06% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $322M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...